However, this trend did not reach statistical significance—likely due to the small number of pre-surgical patients still awaiting surgery at 6 months.
← all excerpts
Results of relugolix/estradiol/norethisterone acetate combination therapy in real-world clinical practice: Effectiveness, tolerability, and factors influencing discontinuation.
1
—
—